Bumann Dirk, Holland Petra, Siejak Frank, Koesling Jan, Sabarth Nicolas, Lamer Stefanie, Zimny-Arndt Ursula, Jungblut Peter R, Meyer Thomas F
Department of Molecular Biology, Max-Planck-Institute for Infection Biology, Berlin, Germany.
Infect Immun. 2002 Nov;70(11):6494-8. doi: 10.1128/IAI.70.11.6494-6498.2002.
Preclinical mouse infection models are widely used for Helicobacter vaccine development, but how well such models mimic important aspects of human infections is unknown. A comparison of Helicobacter pylori immunoproteomes of infected mice with previously reported patient data reveals a high agreement in the antigens recognized, suggesting that H. pylori in vivo protein composition and recognition by the host immune system are comparable in mice and humans. Murine Helicobacter models may thus be valid to screen antigens for human vaccination.
临床前小鼠感染模型广泛用于幽门螺杆菌疫苗的研发，但此类模型对人类感染重要方面的模拟程度尚不清楚。将感染小鼠的幽门螺杆菌免疫蛋白质组与先前报道的患者数据进行比较，结果显示在识别出的抗原方面高度一致，这表明小鼠和人类体内幽门螺杆菌的蛋白质组成以及宿主免疫系统对其的识别具有可比性。因此，小鼠幽门螺杆菌模型可能适用于筛选人类疫苗的抗原。
